Latest filing published 14 Jan 2025 for bioAffinity Technologies, Inc.. Read the official filing
No signal scores available.
This profile gathers the share dealings of Timothy P. Zannes in bioAffinity Technologies, Inc. Over a trading history stretching from 17 November 2022 to 10 January 2025, the count stands at 4 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 14 January 2025 came the latest disclosure, a share grant in bioAffinity Technologies, Inc. Typically, a trade is published a median of 11 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations